品牌 | 其他品牌 | 适用领域 | 科研 |
---|---|---|---|
产地 | 进口 | 加工定制 | 是 |
Chiralix 广州鸿程代理
广州鸿程生物有限公司一家专注于生命科学的科技企业,由在国内科研试剂领域有着丰富从业经验的技术团队和管理团队组建而成,专营进口生物试剂,科学仪器,实验消耗品等。公司将不断把上优质的产品引入国内市场,满足客户的需求,公司也将紧跟生命科学的发展,为广大科研工作者探索生命科学的奥秘奉献绵薄之力.专门从事以抗cuxiao Beckman A63881的磁珠 现货,moltox 11-101.5等现货,transgenomic 706020/706025现货,Megazyme的大部分现货,LIST现货,、ALZET大量现货,Avanti 、tedpella 、BioLegend、Polyplus、jena bioscience、Mattek、MRC-Holland、polysciences、enzo、novus、TOCRIS、CAYMAN、Neuro Probe、cyguns、eylabs、NIBSC、chondrex、lc laboratories、BTI、etonbio
Chiralix是一家专业从事手性有机分子合成和供应的公司,我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身,具备灵活与高效的多种手性分子合成工艺,如基团的氨基酸,叠氮酸,氨基醇及多种肽段模块。除了提供大量的手性分子成品,我们还提供优质的研发服务,如复杂有机分子的合成等。
公司主要产品:
1、氨基酸类:包括各种以氨基酸为骨架的手性衍生物。
货号 | 品名 | 化学名 | CAS号 | 分子量 | 分子式 | Synonyms | 纯度 | 包装 | 价格 |
CX90418-1G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 1 G | 6200 |
CX90418-2G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 2 G | 10600 |
CX90418-5G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 5 G | 19900 |
CX60325-200MG | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 200 MG | 4800 |
CX60325-500MG | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 500 MG | 9800 |
CX60325-1G | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 1 G | 16000 |
CX80065-500MG | Fmoc-L-homopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | 942518-21-0 | 349.38 | C21 H19 N O4 | Fmoc-Hpg-OH | >97% | 500 MG | 11200 |
CX80065-1G | Fmoc-L-homopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | 942518-21-0 | 349.38 | C21 H19 N O4 | Fmoc-Hpg-OH | >97% | 1 G | 18400 |
CX90138-200MG | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 200 MG | 4800 |
CX90138-500MG | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 500 MG | 9800 |
CX90138-1G | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 1 G | 16000 |
CX56292-500MG | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | 108646-25-9 | 156.14 | C7 H8 O4 | >97% | 500 MG | 6000 | |
CX56292-1G | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | 108646-25-9 | 156.14 | C7 H8 O4 | >97% | 1 G | 9800 | |
CX24022-500MG | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | 38127-17-2 | 155.15 | C7 H9 N O3 | >98% | 500 MG | 6000 | |
CX24022-1G | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | 38127-17-2 | 155.15 | C7 H9 N O3 | >98% | 1 G | 9800 | |
CX41399-1G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 1 G | 2200 | |
CX41399-2G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 2 G | 3800 | |
CX41399-5G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 5 G | 7200 | |
CX64691-1G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 1 G | 2200 |
CX64691-2G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 2 G | 3800 |
CX64691-5G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 5 G | 7200 |
CX97471-500MG | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 500 MG | 5200 |
CX97471-1G | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 1 G | 9000 |
CX97471-2G | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 2 G | 14800 |
CX58692-1G | (S)-allylglycinol hydrochloride | (S)-2-aminopent-4-en-1-ol hydrochloride | 926660-03-9 | 137.61 | C5 H12 Cl N O | >98% | 1 G | 7400 | |
CX58692-2G | (S)-allylglycinol hydrochloride | (S)-2-aminopent-4-en-1-ol hydrochloride | 926660-03-9 | 137.61 | C5 H12 Cl N O | >98% | 2 G | 12800 | |
CX40529-1G | (S)-propargylglycinol hydrochloride | (S)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 1 G | 8200 | |
CX40529-2G | (S)-propargylglycinol hydrochloride | (S)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 2 G | 14000 | |
CX80916-500MG | bis(N-Cbz)-2-deoxystreptamine | benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 6216-32-6 | 430.45 | C22 H26 N2 O7 | bis-Z-2-DOS | >95% | 500 MG | 6200 |
CX80916-1G | bis(N-Cbz)-2-deoxystreptamine | benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 6216-32-6 | 430.45 | C22 H26 N2 O7 | bis-Z-2-DOS | >95% | 1 G | 10800 |
CX93851-100MG | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 100 MG | 3800 | |
CX93851-500MG | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 500 MG | 12600 | |
CX93851-1G | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 1 G | 19600 | |
CX19922-1G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 1 G | 3000 | |
CX19922-2G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 2 G | 5200 | |
CX19922-5G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 5 G | 9800 | |
CX62577-10MG | 6,8a-diepi-castanospermine | (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol | 106798-21-0 | 189.21 | C8 H15 N O4 | >98% | 10 MG | 3600 | |
CX62577-50MG | 6,8a-diepi-castanospermine | (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol | 106798-21-0 | 189.21 | C8 H15 N O4 | >98% | 50 MG | 11800 | |
CX25404-1G | Fmoc-L-azidoornithine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid | 1097192-04-5 | 380.40 | C20 H20 N4 O4 | Fmoc-Orn(N2)-OH | >98% | 1 G | 3400 |
CX25404-5G | Fmoc-L-azidoornithine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid | 1097192-04-5 | 380.40 | C20 H20 N4 O4 | Fmoc-Orn(N2)-OH | >98% | 5 G | 12000 |
CX23880-5MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 5 MG | 5000 | |
CX23880-20MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 20 MG | 15000 | |
CX23880-100MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 100 MG | 35000 | |
CX38605-1G | Fmoc-L-allysine ethylene acetal | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 411.45 | C23 H25 N O6 | Fmoc-Aea-OH | >97% | 1 G | 7200 |
CX38605-2G | Fmoc-L-allysine ethylene acetal | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 411.45 | C23 H25 N O6 | Fmoc-Aea-OH | >97% | 2 G | 12400 |
CX59650-1G | Fmoc-L-azidohomoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid | 942518-20-9 | 366.37 | C19 H18 N4 O4 | Fmoc-Azh-OH | >98% | 1 G | 3400 |
CX59650-5G | Fmoc-L-azidohomoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid | 942518-20-9 | 366.37 | C19 H18 N4 O4 | Fmoc-Azh-OH | >98% | 5 G | 12000 |
CX94894-200MG | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 200 MG | 4400 |
CX94894-500MG | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 500 MG | 9000 |
CX94894-1G | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 1 G | 14600 |
CX13745-1G | (R)-propargylglycinol hydrochloride | (R)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 1 G | 8200 | |
CX13745-2G | (R)-propargylglycinol hydrochloride | (R)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 2 G | 14000 | |
CX78500-1G | (R)-allylglycinol hydrochloride | (R)-2-aminopent-4-en-1-ol hydrochloride | 926660-30-2 | 137.61 | C5 H12 Cl N O | >98% | 1 G | 7400 | |
CX78500-2G | (R)-allylglycinol hydrochloride | (R)-2-aminopent-4-en-1-ol hydrochloride | 926660-30-2 | 137.61 | C5 H12 Cl N O | >98% | 2 G | 12800 | |
CX69324-500MG | bis(N-Boc)-2-deoxystreptamine | tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 189157-45-7 | 362.42 | C16 H30 N2 O7 | bis-Boc-2-DOS | >95% | 500 MG | 6200 |
CX69324-1G | bis(N-Boc)-2-deoxystreptamine | tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 189157-45-7 | 362.42 | C16 H30 N2 O7 | bis-Boc-2-DOS | >95% | 1 G | 10800 |
CX96388-1G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 1 G | 6200 |
CX96388-2G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 2 G | 10600 |
CX96388-5G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 5 G | 19900 |
CX42388-1G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 1 G | 6200 |
CX42388-2G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 2 G | 10600 |
CX42388-5G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 5 G | 19900 |
CX44656-500MG | Boc-L-homopropargylglycine | (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | 208522-16-1 | 227.26 | C11 H17 N O4 | Boc-Hpg-OH | >98% | 500 MG | 9800 |
CX44656-1G | Boc-L-homopropargylglycine | (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | 208522-16-1 | 227.26 | C11 H17 N O4 | Boc-Hpg-OH | >98% | 1 G | 16000 |
CX69013-500MG | Cbz-L-homopropargylglycine | (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-Hpg-OH | >98% | 500 MG | 9800 |
CX69013-1G | Cbz-L-homopropargylglycine | (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-Hpg-OH | >98% | 1 G | 16000 |
CX54783-500MG | Boc-D-homopropargylglycine | (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | Not available | 227.26 | C11 H17 N O4 | Boc-D-Hpg-OH | >98% | 500 MG | 9800 |
CX54783-1G | Boc-D-homopropargylglycine | (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | Not available | 227.26 | C11 H17 N O4 | Boc-D-Hpg-OH | >98% | 1 G | 16000 |
CX14845-500MG | Cbz-D-homopropargylglycine | (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-D-Hpg-OH | >98% | 500 MG | 9800 |
CX14845-1G | Cbz-D-homopropargylglycine | (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-D-Hpg-OH | >98% | 1 G | 16000 |
CX87818-500MG | Fmoc-D-homopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | Not available | 349.38 | C21 H19 N O4 | Fmoc-D-Hpg-OH | >97% | 500 MG | 11200 |
CX87818-1G | Fmoc-D-homopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | Not available | 349.38 | C21 H19 N O4 | Fmoc-D-Hpg-OH | >97% | 1 G | 18400 |
CX57816-500MG | Fmoc-L-bishomopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-Bpg-OH | >97% | 500 MG | 10400 |
CX57816-1G | Fmoc-L-bishomopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-Bpg-OH | >97% | 1 G | 16800 |
CX32424-200MG | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 200 MG | 4400 |
CX32424-500MG | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 500 MG | 9000 |
CX32424-1G | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 1 G | 14600 |
CX80846-500MG | Fmoc-D-bishomopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-D-Bpg-OH | >97% | 500 MG | 10400 |
CX80846-1G | Fmoc-D-bishomopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-D-Bpg-OH | >97% | 1 G | 16800 |
CX52977-1G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 1 G | 2200 | |
CX52977-2G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 2 G | 3800 | |
CX52977-5G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 5 G | 7200 | |
CX79659-1G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 1 G | 2200 | |
CX79659-2G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 2 G | 3800 | |
CX79659-5G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 5 G | 7200 | |
CX56872-1G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 1 G | 2600 | |
CX56872-2G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 2 G | 4400 | |
CX56872-5G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 5 G | 8600 | |
CX44048-1G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 1 G | 2200 |
CX44048-2G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 2 G | 3800 |
CX44048-5G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 5 G | 7200 |
CX22855-1G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 1 G | 2600 |
CX22855-2G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 2 G | 4400 |
CX22855-5G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 5 G | 8600 |
CX28901-1G | (S)-Boc-alpha-methyl-phenylglycine | (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid | 802541-88-4 | 265.30 | C14 H19 N O4 | (S)-Boc-Mpg-OH | >98% | 1 G | 9000 |
CX28901-2G | (S)-Boc-alpha-methyl-phenylglycine | (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid | 802541-88-4 | 265.30 | C14 H19 N O4 | (S)-Boc-Mpg-OH | >98% | 2 G | 14800 |
CX28344-1G | (S)-Fmoc-alpha-methyl-phenylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881921-11-5 | 387.43 | C24 H21 N O4 | (S)-Fmoc-Mpg-OH | >98% | 1 G | 10400 |
CX28344-2G | (S)-Fmoc-alpha-methyl-phenylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881921-11-5 | 387.43 | C24 H21 N O4 | (S)-Fmoc-Mpg-OH | >98% | 2 G | 17200 |
CX93005-1G | Fmoc-L-azidoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid | 684270-46-0 | 352.34 | C18 H16 N4 O4 | Fmoc-Aza-OH | >98% | 1 G | 3400 |
CX93005-5G | Fmoc-L-azidoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid | 684270-46-0 | 352.34 | C18 H16 N4 O4 | Fmoc-Aza-OH | >98% | 5 G | 12000 |
CX90286-200MG | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 200 MG | 4200 |
CX90286-500MG | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 500 MG | 8800 |
CX90286-1G | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 1 G | 15200 |
CX44848-200MG | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | |
CX44848-500MG | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | |
CX44848-1G | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | |
CX45124-500MG | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 500 MG | 6200 |
CX45124-1G | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 1 G | 10400 |
CX45124-2G | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 2 G | 17200 |
CX43844-1G | L-azidoleucine CHA salt | cyclohexanaminium (S)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Leu-OH · CHA | >98% | 1 G | 2800 |
CX43844-5G | L-azidoleucine CHA salt | cyclohexanaminium (S)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Leu-OH · CHA | >98% | 5 G | 10600 |
CX66793-1G | L-azidovaline CHA salt | cyclohexanaminium (S)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-Val-OH · CHA | >98% | 1 G | 2600 |
CX66793-5G | L-azidovaline CHA salt | cyclohexanaminium (S)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-Val-OH · CHA | >98% | 5 G | 9800 |
CX90285-1G | L-azidotryptophan CHA salt | cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-Trp-OH · CHA | >98% | 1 G | 2400 |
CX90285-5G | L-azidotryptophan CHA salt | cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-Trp-OH · CHA | >98% | 5 G | 9000 |
CX32182-1G | L-azidoalanine CHA salt | cyclohexanaminium (S)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-Ala-OH · CHA | >98% | 1 G | 2800 |
CX32182-5G | L-azidoalanine CHA salt | cyclohexanaminium (S)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-Ala-OH · CHA | >98% | 5 G | 10600 |
CX33085-1G | L-azidophenylalanine CHA salt | cyclohexanaminium (S)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | N3-Phe-OH · CHA | >98% | 1 G | 2400 |
CX33085-5G | L-azidophenylalanine CHA salt | cyclohexanaminium (S)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | N3-Phe-OH · CHA | >98% | 5 G | 9000 |
CX37236-1G | L-azidoisoleucine CHA salt | cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Ile-OH · CHA | >98% | 1 G | 2800 |
CX37236-5G | L-azidoisoleucine CHA salt | cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Ile-OH · CHA | >98% | 5 G | 10600 |
CX81236-1G | L-azidotyrosine CHA salt | cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-Tyr-OH · CHA | >97% | 1 G | 2800 |
CX81236-5G | L-azidotyrosine CHA salt | cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-Tyr-OH · CHA | >97% | 5 G | 10600 |
CX84940-1G | L-azidomethionine CHA salt | cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-Met-OH · CHA | >98% | 1 G | 2600 |
CX84940-5G | L-azidomethionine CHA salt | cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-Met-OH · CHA | >98% | 5 G | 9800 |
CX81456-200MG | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | |
CX81456-500MG | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | |
CX81456-1G | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | |
CX80632-1G | L-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-Thr(OtBu)-OH · CHA | >98% | 1 G | 2800 |
CX80632-5G | L-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-Thr(OtBu)-OH · CHA | >98% | 5 G | 10600 |
CX59871-1G | L-azidoserine CHA salt | cyclohexanaminium (S)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-Ser-OH · CHA | >98% | 1 G | 2600 |
CX59871-5G | L-azidoserine CHA salt | cyclohexanaminium (S)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-Ser-OH · CHA | >98% | 5 G | 9800 |
CX20625-1G | L-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-Asp(OtBu)-OH · CHA | >98% | 1 G | 2600 |
CX20625-5G | L-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-Asp(OtBu)-OH · CHA | >98% | 5 G | 9800 |
CX24163-1G | L-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-Glu(OtBu)-OH · CHA | >98% | 1 G | 2800 |
CX24163-5G | L-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-Glu(OtBu)-OH · CHA | >98% | 5 G | 10600 |
CX68680-1G | L-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-Tyr(OtBu)-OH · CHA | >98% | 1 G | 2800 |
CX68680-5G | L-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-Tyr(OtBu)-OH · CHA | >98% | 5 G | 10600 |
CX55921-1G | L-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-Ser(OtBu)-OH · CHA | >98% | 1 G | 2800 |
CX55921-5G | L-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-Ser(OtBu)-OH · CHA | >98% | 5 G | 10600 |
CX54776-200MG | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | |
CX54776-500MG | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | |
CX54776-1G | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | |
CX46058-1G | D-azidovaline CHA salt | cyclohexanaminium (R)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-D-Val-OH · CHA | >98% | 1 G | 3000 |
CX46058-5G | D-azidovaline CHA salt | cyclohexanaminium (R)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-D-Val-OH · CHA | >98% | 5 G | 11200 |
CX44158-1G | D-azidoalanine CHA salt | cyclohexanaminium (R)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-D-Ala-OH · CHA | >98% | 1 G | 3400 |
CX44158-5G | D-azidoalanine CHA salt | cyclohexanaminium (R)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-D-Ala-OH · CHA | >98% | 5 G | 12800 |
CX27954-1G | D-azidophenylalanine CHA salt | cyclohexanaminium (R)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | D-N3-Phe-OH · CHA | >98% | 1 G | 2800 |
CX27954-5G | D-azidophenylalanine CHA salt | cyclohexanaminium (R)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | D-N3-Phe-OH · CHA | >98% | 5 G | 10600 |
CX56656-1G | D-azidomethionine CHA salt | cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-D-Met-OH · CHA | >98% | 1 G | 2800 |
CX56656-5G | D-azidomethionine CHA salt | cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-D-Met-OH · CHA | >98% | 5 G | 10600 |
CX16129-500MG | Cbz-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-Bpg-OH · CHA | >98% | 500 MG | 9000 |
CX16129-1G | Cbz-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-Bpg-OH · CHA | >98% | 1 G | 14600 |
CX65817-1G | (S)-Cbz-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate | Not available | 398.50 | C23 H30 N2 O4 | (S)-Cbz-Mpg-OH · CHA | >98% | 1 G | 9000 |
CX65817-2G | (S)-Cbz-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate | Not available | 398.50 | C23 H30 N2 O4 | (S)-Cbz-Mpg-OH · CHA | >98% | 2 G | 14800 |
CX19691-500MG | Boc-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-D-Bpg-OH · CHA | >98% | 500 MG | 9000 |
CX19691-1G | Boc-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-D-Bpg-OH · CHA | >98% | 1 G | 14600 |
CX59796-500MG | Boc-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-Bpg-OH · CHA | >98% | 500 MG | 9000 |
CX59796-1G | Boc-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-Bpg-OH · CHA | >98% | 1 G | 14600 |
CX79723-1G | (R)-Fmoc-alpha-methyl-phenylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881920-86-1 | 387.43 | C24 H21 N O4 | (R)-Fmoc-Mpg-OH | >98% | 1 G | 12000 |
CX79723-2G | (R)-Fmoc-alpha-methyl-phenylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881920-86-1 | 387.43 | C24 H21 N O4 | (R)-Fmoc-Mpg-OH | >98% | 2 G | 19800 |
CX32015-1G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 1 G | 2200 |
CX32015-2G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 2 G | 3800 |
CX32015-5G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 5 G | 7200 |
CX81118-1G | Fmoc-L-azidolysine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid | 159610-89-6 | 394.42 | C21 H22 N4 O4 | Fmoc-Lys(N2)-OH | >98% | 1 G | 3400 |
CX81118-5G | Fmoc-L-azidolysine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid | 159610-89-6 | 394.42 | C21 H22 N4 O4 | Fmoc-Lys(N2)-OH | >98% | 5 G | 12000 |
CX19587-500MG | Cbz-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-D-Bpg-OH · CHA | >98% | 500 MG | 9000 |
CX19587-1G | Cbz-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-D-Bpg-OH · CHA | >98% | 1 G | 14600 |
CX28021-500MG | H-Arg(Boc)2-pNA | (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate | Not available | 494.54 | C22 H34 N6 O7 | >97% | 500 MG | 6000 | |
CX28021-1G | H-Arg(Boc)2-pNA | (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate | Not available | 494.54 | C22 H34 N6 O7 | >97% | 1 G | 11000 | |
CX72798-1G | D-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-D-Asp(OtBu)-OH · CHA | >98% | 1 G | 6200 |
CX72798-5G | D-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-D-Asp(OtBu)-OH · CHA | >98% | 5 G | 23400 |
CX93516-1G | D-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-D-Glu(OtBu)-OH · CHA | >98% | 1 G | 5200 |
CX93516-5G | D-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-D-Glu(OtBu)-OH · CHA | >98% | 5 G | 19600 |
CX76762-1G | D-azidoleucine CHA salt | cyclohexanaminium (R)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Leu-OH · CHA | >98% | 1 G | 3000 |
CX76762-5G | D-azidoleucine CHA salt | cyclohexanaminium (R)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Leu-OH · CHA | >98% | 5 G | 11200 |
CX53333-1G | D-azidoisoleucine CHA salt | cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Ile-OH · CHA | >98% | 1 G | 9200 |
CX53333-2G | D-azidoisoleucine CHA salt | cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Ile-OH · CHA | >98% | 2 G | 16400 |
CX83245-1G | D-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-D-Tyr(OtBu)-OH · CHA | >98% | 1 G | 5400 |
CX83245-5G | D-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-D-Tyr(OtBu)-OH · CHA | >98% | 5 G | 20400 |
CX13425-1G | D-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-D-Ser(OtBu)-OH · CHA | >98% | 1 G | 7200 |
CX13425-5G | D-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-D-Ser(OtBu)-OH · CHA | >98% | 5 G | 27200 |
CX29937-1G | D-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-D-Thr(OtBu)-OH · CHA | >98% | 1 G | 6400 |
CX29937-5G | D-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-D-Thr(OtBu)-OH · CHA | >98% | 5 G | 24200 |
CX85233-1G | L-azidothreonine CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-Thr-OH · CHA | >98% | 1 G | 2600 |
CX85233-5G | L-azidothreonine CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-Thr-OH · CHA | >98% | 5 G | 9800 |
CX37313-1G | D-azidothreonine CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-D-Thr-OH · CHA | >98% | 1 G | 3000 |
CX37313-5G | D-azidothreonine CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-D-Thr-OH · CHA | >98% | 5 G | 11200 |
CX95405-1G | D-azidoserine CHA salt | cyclohexanaminium (R)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-D-Ser-OH · CHA | >98% | 1 G | 3200 |
CX95405-5G | D-azidoserine CHA salt | cyclohexanaminium (R)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-D-Ser-OH · CHA | >98% | 5 G | 12000 |
CX57717-1G | L-azidoglutamine DCHA salt | dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-Gln-OH · DCHA | >98% | 1 G | 2600 |
CX57717-5G | L-azidoglutamine DCHA salt | dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-Gln-OH · DCHA | >98% | 5 G | 9800 |
CX79807-1G | D-azidoglutamine DCHA salt | dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-D-Gln-OH · DCHA | >98% | 1 G | 3200 |
CX79807-5G | D-azidoglutamine DCHA salt | dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-D-Gln-OH · DCHA | >98% | 5 G | 12000 |
CX94556-1G | L-azidoasparagine DCHA salt | dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate | 79410-49-4 | 339.43 | C16 H29 N5 O3 | N3-Asn-OH · DCHA | >98% | 1 G | 3200 |
CX94556-5G | L-azidoasparagine DCHA salt | dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate | 79410-49-4 | 339.43 | C16 H29 N5 O3 | N3-Asn-OH · DCHA | >98% | 5 G | 12000 |
CX83100-1G | D-azidoasparagine DCHA salt | dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate | Not available | 339.43 | C16 H29 N5 O3 | N3-D-Asn-OH · DCHA | >98% | 1 G | 4000 |
CX83100-5G | D-azidoasparagine DCHA salt | dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate | Not available | 339.43 | C16 H29 N5 O3 | N3-D-Asn-OH · DCHA | >98% | 5 G | 15000 |
CX48141-1G | D-azidotryptophan CHA salt | cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-D-Trp-OH · CHA | >98% | 1 G | 2600 |
CX48141-5G | D-azidotryptophan CHA salt | cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-D-Trp-OH · CHA | >98% | 5 G | 9800 |
CX93426-1G | N-im-trityl-L-azidohistidine CHA salt | cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate | Not available | 522.64 | C31 H34 N6 O2 | N3-His(Trt)-OH · CHA | >98% | 1 G | 4000 |
CX93426-5G | N-im-trityl-L-azidohistidine CHA salt | cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate | Not available | 522.64 | C31 H34 N6 O2 | N3-His(Trt)-OH · CHA | >98% | 5 G | 15000 |
CX24279-1G | D-azidotyrosine CHA salt | cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-D-Tyr-OH · CHA | >98% | 1 G | 3600 |
CX24279-5G | D-azidotyrosine CHA salt | cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-D-Tyr-OH · CHA | >98% | 5 G | 13600 |
CX78063-1G | L-azido-tert-leucine CHA salt | cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-tert-Leu-OH · CHA | >98% | 1 G | 2800 |
CX78063-5G | L-azido-tert-leucine CHA salt | cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-tert-Leu-OH · CHA | >98% | 5 G | 10600 |
CX30547-1G | D-azido-tert-leucine CHA salt | cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-tert-Leu-OH · CHA | >98% | 1 G | 6600 |
CX30547-5G | D-azido-tert-leucine CHA salt | cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-tert-Leu-OH · CHA | >98% | 5 G | 25000 |
CX78942-1G | L-azidoallylglycine CHA salt | cyclohexanaminium (S)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-Alg-OH · CHA | >98% | 1 G | 5600 |
CX78942-5G | L-azidoallylglycine CHA salt | cyclohexanaminium (S)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-Alg-OH · CHA | >98% | 5 G | 21200 |
CX61332-1G | D-azidoallylglycine CHA salt | cyclohexanaminium (R)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-D-Alg-OH · CHA | >98% | 1 G | 9000 |
CX61332-2G | D-azidoallylglycine CHA salt | cyclohexanaminium (R)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-D-Alg-OH · CHA | >98% | 2 G | 16000 |
CX56925-1G | Ng-Pmc-L-azidoarginine | (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid | Not available | 466.55 | C20 H30 N6 O5 S | Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine | >95% | 1 G | 4000 |
CX56925-5G | Ng-Pmc-L-azidoarginine | (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid | Not available | 466.55 | C20 H30 N6 O5 S | Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine | >95% | 5 G | 15000 |
CX22361-1G | (S)-azido-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (S)-N3-Mpg-OH · CHA | >98% | 1 G | 9000 |
CX22361-2G | (S)-azido-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (S)-N3-Mpg-OH · CHA | >98% | 2 G | 14800 |
CX52265-1G | (R)-azido-alpha-methylphenylglycine CHA salt | cyclohexanaminium (R)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (R)-N3-Mpg-OH · CHA | >98% | 1 G | 10400 |
CX52265-2G | (R)-azido-alpha-methylphenylglycine CHA salt | cyclohexanaminium (R)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (R)-N3-Mpg-OH · CHA | >98% | 2 G | 17200 |
CX71813-1G | S-Trityl-L-azidocysteine CHA salt | cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate | Not available | 488.64 | C28 H32 N4 O2 S | N3-Cys(Trt)-OH · CHA | >98% | 1 G | 3000 |
CX71813-5G | S-Trityl-L-azidocysteine CHA salt | cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate | Not available | 488.64 | C28 H32 N4 O2 S | N3-Cys(Trt)-OH · CHA | >98% | 5 G | 11200 |
CX40608-5G | 6-azidohexanoic acid | 6-azidohexanoic acid | 79598-53-1 | 157.17 | C6 H11 N3 O2 | >98% | 5 G | 6000 | |
CX40608-10G | 6-azidohexanoic acid | 6-azidohexanoic acid | 79598-53-1 | 157.17 | C6 H11 N3 O2 | >98% | 10 G | 11000 | |
CX23053-500MG | (S)-bishomopropargylglycinol hydrochloride | (S)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 500 MG | 10400 | |
CX23053-1G | (S)-bishomopropargylglycinol hydrochloride | (S)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 1 G | 17200 | |
CX63523-500MG | (R)-bishomopropargylglycinol hydrochloride | (R)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 500 MG | 10400 | |
CX63523-1G | (R)-bishomopropargylglycinol hydrochloride | (R)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 1 G | 17200 | |
CX69091-500MG | (R)-homopropargylglycinol hydrochloride | (R)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 500 MG | 11000 | |
CX69091-1G | (R)-homopropargylglycinol hydrochloride | (R)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 1 G | 17800 | |
CX76358-500MG | (S)-homopropargylglycinol hydrochloride | (S)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 500 MG | 11000 | |
CX76358-1G | (S)-homopropargylglycinol hydrochloride | (S)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 1 G | 17800 | |
CX55029-2MG | cereulide | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | Not available | 1153.40 | C57 H96 N6 O18 | >95% | 2 MG | 12000 | |
CX55029-5MG | cereulide | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | Not available | 1153.40 | C57 H96 N6 O18 | >95% | 5 MG | 24000 | |
CX45120-1G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 1 G | 4000 | |
CX45120-2G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 2 G | 9000 | |
CX45120-5G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 5 G | 15000 | |
CX57163-2MG | 13C6-cereulide | cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 | Not available | 1159.36 | C51 13 C6 H96 N6 O18 | >95% | 2 MG | 24000 | |
CX64158-1G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 1 G | 4000 |
CX64158-2G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 2 G | 7200 |
CX64158-5G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 5 G | 15000 |
CX80044-250MG | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 250 MG | 7600 | |
CX80044-500MG | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 500 MG | 14000 | |
CX80044-1G | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 1 G | 25000 | |
CX67830-250MG | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 250 MG | 7800 | |
CX67830-500MG | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 500 MG | 14400 | |
CX67830-1G | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 1 G | 26000 | |
CX18326-1G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 1 G | 5000 | |
CX18326-2G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 2 G | 9000 | |
CX18326-5G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 5 G | 19000 | |
CX59077-1G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 1 G | 6000 | |
CX59077-2G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 2 G | 10800 | |
CX59077-5G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 5 G | 22000 | |
CX48623-1G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 1 G | 5000 | |
CX48623-2G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 2 G | 9000 | |
CX48623-5G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 5 G | 19000 | |
CX55361-500MG | H-Arg(Boc)2-AMC | H-Arg(Boc)2-AMC | Not available | 531.60 | C26 H37 N5 O7 | >97% | 500 MG | 6000 | |
CX55361-1G | H-Arg(Boc)2-AMC | H-Arg(Boc)2-AMC | Not available | 531.60 | C26 H37 N5 O7 | >97% | 1 G | 10800 | |
CX84944-1G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 1 G | 4000 | |
CX84944-2G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 2 G | 7200 | |
CX84944-5G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 5 G | 15000 | |
CX69359-5G | 4-azidobutyric acid | 4-azidobutanoic acid | 54447-68-6 | 129.12 | C4 H7 N3 O2 | gamma-azidobutyric acid | >98% | 5 G | 6000 |
CX69359-10G | 4-azidobutyric acid | 4-azidobutanoic acid | 54447-68-6 | 129.12 | C4 H7 N3 O2 | gamma-azidobutyric acid | >98% | 10 G | 11000 |
CX31309-5G | 5-azidovaleric acid | 5-azidopentanoic acid | 79583-98-5 | 143.14 | C5 H9 N3 O2 | delta-azidovaleric acid | >98% | 5 G | 6600 |
CX31309-10G | 5-azidovaleric acid | 5-azidopentanoic acid | 79583-98-5 | 143.14 | C5 H9 N3 O2 | delta-azidovaleric acid | >98% | 10 G | 11800 |
CX98490-5G | 7-azidoheptanoic acid | 7-azidoheptanoic acid | 135920-28-4 | 171.20 | C7 H13 N3 O2 | >98% | 5 G | 6000 | |
CX98490-10G | 7-azidoheptanoic acid | 7-azidoheptanoic acid | 135920-28-4 | 171.20 | C7 H13 N3 O2 | >98% | 10 G | 11000 | |
CX65527-1G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 1 G | 2800 | |
CX65527-5G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 5 G | 10600 | |
CX65527-10G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 10 G | 17000 | |
CX61074-200MG | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 200 MG | 4800 |
CX61074-500MG | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 500 MG | 9800 |
CX61074-1G | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 1 G | 16000 |
CX39389-200MG | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 200 MG | 4800 |
CX39389-500MG | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 500 MG | 9800 |
CX39389-1G | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 1 G | 16000 |
CX80391-200MG | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 200 MG | 4800 |
CX80391-500MG | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 500 MG | 9800 |
CX80391-1G | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 1 G | 16000 |
CX82876-200MG | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 200 MG | 4800 |
CX82876-500MG | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 500 MG | 9800 |
CX82876-1G | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 1 G | 16000 |
CX93488-1MG | (±)-sorgolactone | (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | Not available | 316.35 | C18 H20 O5 | racemic sorgolactone | >98% | 1 MG | 4000 |
CX93488-5MG | (±)-sorgolactone | (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | Not available | 316.35 | C18 H20 O5 | racemic sorgolactone | >98% | 5 MG | 15000 |
CX64382-1MG | (±)-strigol | (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | 51820-11-2 | 346.37 | C19 H22 O6 | >98% | 1 MG | 5000 | |
CX64382-5MG | (±)-strigol | (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | 51820-11-2 | 346.37 | C19 H22 O6 | >98% | 5 MG | 18800 | |
CX88057-10MG | Nijmegen-1 | (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate | 159155-03-0 | 343.29 | C17 H13 N O7 | >98% | 10 MG | 3600 | |
CX88057-50MG | Nijmegen-1 | (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate | 159155-03-0 | 343.29 | C17 H13 N O7 | >98% | 50 MG | 11800 | |
CX42450-200MG | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 200 MG | 4800 |
CX42450-500MG | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 500 MG | 9800 |
CX42450-1G | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 1 G | 16000 |
CX35419-200MG | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 200 MG | 4800 |
CX35419-500MG | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 500 MG | 9800 |
CX35419-1G | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 1 G | 16000 |
CX11583-200MG | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 200 MG | 4800 |
CX11583-500MG | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 500 MG | 9800 |
CX11583-1G | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 1 G | 16000 |
CX92224-200MG | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 200 MG | 4800 |
CX92224-500MG | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 500 MG | 9800 |
CX92224-1G | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 1 G | 16000 |
CX81018-500MG | (S)-Fmoc-beta2-homoalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | 203854-58-4 | 325.36 | C19 H19 N O4 | (S)-Fmoc-beta2-hAla-OH | >98% | 500 MG | 11200 |
CX81018-1G | (S)-Fmoc-beta2-homoalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | 203854-58-4 | 325.36 | C19 H19 N O4 | (S)-Fmoc-beta2-hAla-OH | >98% | 1 G | 18400 |
CX85919-500MG | (R)-Fmoc-beta2-homoalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | Not available | 325.36 | C19 H19 N O4 | (R)-Fmoc-beta2-hAla-OH | >98% | 500 MG | 11200 |
CX85919-1G | (R)-Fmoc-beta2-homoalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | Not available | 325.36 | C19 H19 N O4 | (R)-Fmoc-beta2-hAla-OH | >98% | 1 G | 18400 |
CX98774-500MG | (R)-Fmoc-beta2-homoleucine | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 1018899-99-4 | 367.44 | C22 H25 N O4 | (R)-Fmoc-beta2-hLeu-OH | >98% | 500 MG | 11200 |
CX98774-1G | (R)-Fmoc-beta2-homoleucine | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 1018899-99-4 | 367.44 | C22 H25 N O4 | (R)-Fmoc-beta2-hLeu-OH | >98% | 1 G | 18400 |
CX33604-500MG | (R)-Fmoc-beta2-homovaline | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | Not available | 353.41 | C21 H23 N O4 | (R)-Fmoc-beta2-hVal-OH | >98% | 500 MG | 11200 |
CX33604-1G | (R)-Fmoc-beta2-homovaline | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | Not available | 353.41 | C21 H23 N O4 | (R)-Fmoc-beta2-hVal-OH | >98% | 1 G | 18400 |
CX82946-500MG | (S)-Fmoc-beta2-homophenylalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 203854-62-0 | 401.45 | C25 H23 N O4 | (S)-Fmoc-beta2-hPhe-OH | >98% | 500 MG | 11200 |
CX82946-1G | (S)-Fmoc-beta2-homophenylalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 203854-62-0 | 401.45 | C25 H23 N O4 | (S)-Fmoc-beta2-hPhe-OH | >98% | 1 G | 18400 |
CX86231-500MG | (S)-Fmoc-beta2-homovaline | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | 203854-59-5 | 353.41 | C21 H23 N O4 | (S)-Fmoc-beta2-hVal-OH | >98% | 500 MG | 11200 |
CX86231-1G | (S)-Fmoc-beta2-homovaline | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | 203854-59-5 | 353.41 | C21 H23 N O4 | (S)-Fmoc-beta2-hVal-OH | >98% | 1 G | 18400 |
CX15046-500MG | (R)-Fmoc-beta2-homophenylalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 828254-16-6 | 401.45 | C25 H23 N O4 | (R)-Fmoc-beta2-hPhe-OH | >98% | 500 MG | 11200 |
CX15046-1G | (R)-Fmoc-beta2-homophenylalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 828254-16-6 | 401.45 | C25 H23 N O4 | (R)-Fmoc-beta2-hPhe-OH | >98% | 1 G | 18400 |
CX30199-500MG | (S)-Fmoc-beta2-homoleucine | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 193887-45-5 | 367.44 | C22 H25 N O4 | (S)-Fmoc-beta2-hLeu-OH | >98% | 500 MG | 11200 |
CX30199-1G | (S)-Fmoc-beta2-homoleucine | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 193887-45-5 | 367.44 | C22 H25 N O4 | (S)-Fmoc-beta2-hLeu-OH | >98% | 1 G | 18400 |
CX20422-1ML | cereulide (50 µg/mL in acetonitrile) | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 (50 µg/mL in acetonitrile) | Not available | 1153.40 | C57 H96 N6 O18 | cereulide stock solution | >95% | 1 ML | 5000 |
CX87778-1ML | 13C6-cereulide (20 µg/mL in acetonitrile) | cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 (20 µg/mL in acetonitrile) | Not available | 1159.36 | C51 13 C6 H96 N6 O18 | 13C6-cereulide stock solution | >95% | 1 ML | 5000 |
CX18112-1G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 3000 | |
CX18112-5G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 7400 | |
CX18112-10G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 10 G | 13200 | |
CX95981-5G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 5 G | 2200 |
CX95981-10G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 10 G | 4000 |
CX95981-25G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 25 G | 8400 |
CX62483-1G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 4200 | |
CX62483-2G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 2 G | 7600 | |
CX62483-5G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 16000 | |
CX80461-1G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 4200 | |
CX80461-2G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 2 G | 7600 | |
CX80461-5G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 16000 | |
CX27597-1G | 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate | 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate | 1185733-70-3 | 457.66 | C8 H10 Cl3 F3 N2 O6 S2 | >98% | 1 G | 2600 | |
CX27597-5G | 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate | 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate | 1185733-70-3 | 457.66 | C8 H10 Cl3 F3 N2 O6 S2 | >98% | 5 G | 9800 | |
CX50506-10MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 10 MG | 3600 | |
CX50506-50MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 50 MG | 13800 | |
CX50506-100MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 100 MG | 23000 | |
CX95469-10MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 10 MG | 3000 |
CX95469-50MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 50 MG | 11400 |
CX95469-100MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 100 MG | 19600 |
CX75854-10MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 10 MG | 3000 | |
CX75854-50MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 50 MG | 11400 | |
CX75854-100MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 100 MG | 19600 | |
CX52612-10MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 10 MG | 3000 | |
CX52612-50MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 50 MG | 11400 | |
CX52612-100MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 100 MG | 19600 | |
CX93797-10G | Fmoc-D-cyclohexylglycine | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 198543-96-3 | 379.45 | C23 H25 N O4 | Fmoc-D-Chg-OH | >97% | 10 G | 6000 |
CX93797-25G | Fmoc-D-cyclohexylglycine | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 198543-96-3 | 379.45 | C23 H25 N O4 | Fmoc-D-Chg-OH | >97% | 25 G | 13000 |
CX29693-10G | Fmoc-L-cyclohexylglycine | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 161321-36-4 | 379.45 | C23 H25 N O4 | Fmoc-L-Chg-OH | >97% | 10 G | 6000 |
CX29693-25G | Fmoc-L-cyclohexylglycine | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 161321-36-4 | 379.45 | C23 H25 N O4 | Fmoc-L-Chg-OH | >97% | 25 G | 13000 |